-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Madrigal Pharmaceuticals, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2022 to Q3 2025.
- Madrigal Pharmaceuticals, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2025 was $287M, a 362% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending September 30, 2025 was $741M.
- Madrigal Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $180M.
- Madrigal Pharmaceuticals, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $0.000.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)